Evidence map›Paper›PMID 23764549›Full record

ArticleCytokine2013

Cytokines are systemic effectors of lymphatic function in acute inflammation.

Melissa B Aldrich, Eva M Sevick-Muraca

Abstract read
In one paragraph

Article in Cytokine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 1 synthesis or guideline pooled it, 123 citations in OpenAlex.

  1. Intrathecal drug delivery in the era of nanomedicine.Advanced drug delivery reviews · 2020
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Hypovolemia with peripheral edema: What is wrong?Critical care (London, England) · 2023
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Melissa B AldrichThe Center for Molecular Imaging, Brown Foundation Institute for Molecular Medicine, The University of Texas Health Science Center-Houston, 1825 Pressler, 330-07, Houston, TX 77030, United States. Electronic address: Melissa.B.Aldrich@uth.tmc.edu.
Eva M Sevick-Muraca
The University of Texas Health Science Center at Houston · US

Funding

Functional lymph angiography with NIR imagingR01HL092923 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI SEVICK, EVA M. · 2008 to 2011
$1.5M
NHLBI NIH HHS R01 HL092923
6 · The paper itself

Abstract

The response of the lymphatic system to inflammatory insult and infection is not completely understood. Using a near-infrared fluorescence (NIRF) imaging system to noninvasively document propulsive function, we noted the short-term cessation of murine lymphatic propulsion as early as 4h following LPS injection. Notably, the effects were systemic, displaying bilateral lymphatic pumping cessation after a unilateral insult. Furthermore, IL-1β, TNF-α, and IL-6, cytokines that were found to be elevated in serum during lymphatic pumping cessation, were shown separately to acutely and systemically decrease lymphatic pulsing frequency and velocity following intradermal administration. Surprisingly, marked lymphatic vessel dilation and leakiness were noted in limbs contralateral to IL-1β intradermal administration, but not in ipsilateral limbs. The effects of IL-1β on lymphatic pumping were abated by pre-treatment with an inhibitor of inducible nitric oxide synthase, L-NIL (N-iminoethyl-L-lysine). The results suggest that lymphatic propulsion is systemically impaired within 4h of acute inflammatory insult, and that some cytokines are major effectors of lymphatic pumping cessation through nitric oxide-mediated mechanisms. These findings may help in understanding the actions of cytokines as mediators of lymphatic function in inflammatory and infectious states.

Indexed as

Acute DiseaseAnimalsCells, CulturedFemaleInflammationInterleukin-1betaInterleukin-6LipopolysaccharidesLymphangiogenesisLymphatic VesselsLysineMiceNitric OxideNitric Oxide Synthase Type IIOptical ImagingTumor Necrosis Factor-alphaInterleukin-1betaInterleukin-6LipopolysaccharidesLysineN(6)-(1-iminoethyl)lysineNitric OxideNitric Oxide Synthase Type IITumor Necrosis Factor-alphaCD14/TLR4/MD2CD14/Toll-like receptor 4/MD2ICGIFN-γILindocyanine greeninducible nitric oxideInflammationiNOSinterferon-gammainterleukinInterleukin-1 betaInterleukin-6LECslipopolysaccharideL-NILLPSLymphaticlymphatic endothelial cellsMCP-1/CCL2monocyte chemoattractant protein-1/chemokine (C–C motif) ligand 2near-infrared fluorescence imagingN-iminoethyl-L-lysineNIRFTh1-typeT helper 1-typeTumor necrosis factor-alpha

Identifiers

PMID23764549
PMCPMC3771384
OpenAlexW2006415604

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.